Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Azienda USL Reggio Emilia - IRCCS
Istanbul University - Cerrahpasa
Global Healthy Living Foundation
Mayo Clinic
Brigham and Women's Hospital